Cover Image

Crizotinib in high risk neuroblastoma: Experience from a tertiary care cancer centre

Saved in:

Bibliographic Details
Main Authors:	Arpit Mittal (Author), Payal Malhotra (Author), Sandeep Jain (Author), Gauri Kapoor (Author)
Format:	Book
Published:	Elsevier, 2022-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Clinical profile and treatment outcome of children with neuroblastoma a single centre experience
by: Sakshi Bhatnagar, et al.
Published: (2022)

Equivalent outcome irrespective of type transplant in acute myeloid leukaemia in children: A report from tertiary care centre
by: Jeevan GM, et al.
Published: (2024)

Pattern and outcome of children with medulloblastoma: A single centre experience from an LMIC
by: Payal Malhotra, et al.
Published: (2022)

Paediatric oncology- welcome guide sheet and facility briefing: An attempt to facilitate parent education for better care of childhood cancer in an LMIC setting
by: Kajal Jaiswal, et al.
Published: (2022)

Incidence, risk factors and outcome of therapy related acute myeloid leukaemia: Single centre experience from a paediatric oncology unit
by: Chintan Vyas, et al.
Published: (2016)

Chemotherapy competencies for pediatric oncology nurses: Standardizing assessment in a single centre in India
by: V.V. Vincy, et al.
Published: (2022)

Uncovering psycho-social needs of childhood cancer survivors with talk therapy
by: Juhi Sharma, et al.
Published: (2022)

Chemotherapy flash cards: A tool for reflection practice for nurses in an LMIC setting
by: Preeti Dabas, et al.
Published: (2022)

Assessing adherence to oral chemotherapeutic drugs during maintenance therapy in acute lymphoblasic leukemia: The determining factors
by: Ishita Tiwari, et al.
Published: (2022)

Crizotinib in treatment of lung cancer
by: Arpita Singh, et al.
Published: (2017)

Crizotinib in treatment of lung cancer
by: Arpita Singh, et al.
Published: (2017)

Navigating intermediate-risk neuroblastoma- behaviour and outcomes from a tertiary care centre
by: Sanjana Sarangarajan, et al.
Published: (2024)

Spectrum of gonadotoxic exposures in survivors of childhood cancer
by: Heena Gajiwala, et al.
Published: (2024)

To study asymptomatic cardiac dysfunction in childhood cancer survivors exposed to Adriamycin
by: Gurpreet Singh, et al.
Published: (2022)

Neuroblastoma with Opsoclonus Myoclonus Ataxia Syndrome- Case series from tertiary care centre
by: V. Sandhya, et al.
Published: (2017)

Treatment of High-Risk Neuroblastoma
by: Julie Krystal, et al.
Published: (2023)

Treatment of high-risk neuroblastoma
by: Ki Woong Sung
Published: (2012)

Profile of cerebrovascular accidents in subjects with or without type 2 diabetes mellitus in intensive care units of tertiary care centre
by: Dinesh Jain, et al.
Published: (2020)

High-Risk Neuroblastoma Treatment Review
by: Valeria Smith, et al.
Published: (2018)

Long-term survey of patients with neuroblastoma treated in a newly established tertiary care cancer centre of North India - An interim analysis
by: Soumitra Saha, et al.
Published: (2024)

High-Risk Neuroblastoma: A Surgical Perspective
by: Jillian C. Jacobson, et al.
Published: (2023)

ALK-driven tumors and targeted therapy: focus on crizotinib
by: Murga-Zamalloa C, et al.
Published: (2014)

Crizotinib-Associated Renal Cysts: A Case Series
by: Garima Suman, et al.
Published: (2019)

Development of 10-Hydroxycamptothecin-crizotinib conjugate based on the synergistic effect on lung cancer cells
by: Zhen Liu, et al.
Published: (2023)

Massive transfusion protocol: Need of the hour - A tertiary care centre experience
by: Lakhvinder Singh, et al.
Published: (2022)

Comparable post-transplant outcomes of high-risk neuroblastoma from a tertiary care unit of low- and middle-income country
by: Shivam Bansal, et al.
Published: (2024)

Comorbidities in paediatric psoriasis: Experience from a tertiary care centre
by: Vibhu Mendiratta, et al.
Published: (2023)

Isotopic Radiolabeling of Crizotinib with Fluorine-18 for In Vivo Pet Imaging
by: Malvika Sardana, et al.
Published: (2022)

High-Risk Neuroblastoma with Metastases to Bilateral Kidneys at Diagnosis
by: Toshihide Yoshikawa, et al.
Published: (2017)

Immunophenotyping of male breast cancer - Experience at a tertiary care centre
by: Sunil Pasricha, et al.
Published: (2019)

Clinical, pathological profile and outcome in pediatric neuroblastoma: Single centre experience from South India
by: Gayathri Sajeevan, et al.
Published: (2022)

Dinutuximab Beta in Children with High-Risk Neuroblastoma: Experience from a Single Center in Croatia
by: Jasminka Stepan Giljević, et al.
Published: (2022)

Impact of covid-19 pandemic on characteristics of dental emergencies and treatment services at tertiary care centre
by: Umesh Kumar, et al.
Published: (2021)

Crizotinib-induced severe photosensitive dermatitis in a carcinoma lung patient
by: T P Afra, et al.
Published: (2021)

Repurposing of the ALK Inhibitor Crizotinib for Acute Leukemia and Multiple Myeloma Cells
by: Joelle C. Boulos, et al.
Published: (2021)

Effect of the patient information brochure in communicating the risks associated with crizotinib treatment to patients with non‐small cell lung cancer (NSCLC) in Europe
by: Kui Huang, et al.
Published: (2020)

Early Use of Dinutuximab Beta in Patients with High-Risk Neuroblastoma
by: Neofit Spasov, et al.
Published: (2021)

Unraveling Gene Fusions for Drug Repositioning in High-Risk Neuroblastoma
by: Zhichao Liu, et al.
Published: (2021)

Prognostic factors for intermediate- or high-risk neuroblastomas in children in China
by: Yi Zhang, et al.
Published: (2023)

Co-delivery of sorafenib and crizotinib encapsulated with polymeric nanoparticles for the treatment of in vivo lung cancer animal model
by: Tian Zhong, et al.
Published: (2021)